Congress Grilled Insurance CEOs for 9 Hours Over This
🏛️ Congress Just Spent 9 Hours Grilling Insurance CEOs About This Exact Thing
In an earlier post, I walked through how a handful of companies own the insurance plan, the pharmacy benefit manager, and often the pharmacy filling your prescription — all under one roof. If that sounded like something only a few of us had noticed, here’s the update: Congress noticed too, and brought the CEOs in to answer for it directly.
📌 A note on this page: this hearing was genuinely bipartisan — Democrats and Republicans both pressed hard, for different reasons. Everything below is drawn from official hearing records and independent, peer-reviewed research, not opinion commentary.
🎤 What Actually Happened
On January 22, 2026, two House committees — Energy and Commerce, and Ways and Means — held a joint hearing running more than nine hours, with the CEOs of UnitedHealth Group, CVS Health, Elevance Health, Cigna, and Blue Shield of California’s parent company all testifying.
Rep. Lori Trahan (D-MA) asked UnitedHealth’s CEO directly where competitive pressure to lower prices is even supposed to come from when the company “owns the insurer, the doctors, the pharmacy benefit managers, and the care delivery system end-to-end.” Republican members pressed their own lines of questioning too — Rep. Jay Obernolte (R-CA) raised concerns about rural patients struggling with access to care, and Rep. Smith (R-NE) questioned rate increases directly. This wasn’t one side going after the industry — both parties had real, separate concerns.
In fairness to the other side of it: UnitedHealth’s CEO defended the integrated structure as creating “a substantial value dynamic,” pointing to better coordination of care, improved use of data, and closer integration of how drugs are made available. That’s his position, on the record, and worth knowing alongside everything else here.
📊 The Numbers That Came Out of It
Rep. Alexandria Ocasio-Cortez (D-NY) cited a 2025 Federal Trade Commission report during the hearing: the three largest pharmacy benefit managers — CVS Caremark, Express Scripts, and OptumRx — marked up specialty generic drugs for cancer, HIV, and other serious conditions by thousands of percent at their own affiliated pharmacies, generating more than $7.3 billion above estimated drug acquisition costs between 2017 and 2022.
Separately, peer-reviewed research from Cornell University, published in the journal Health Affairs, found that UnitedHealthcare pays its own Optum-affiliated physicians 17% more than it pays non-Optum physicians for comparable care — independent academic confirmation, not just a claim made in a hearing room.
For a sense of scale: UnitedHealth Group is now made up of more than 2,600 subsidiaries, has contractual ties to roughly 10% of the entire US physician workforce, and controls about 21% of the pharmacy benefit management market through OptumRx alone.
➡️ What’s Next, and What This Means for You
In February 2026, senators introduced a bill specifically aimed at breaking up vertically integrated insurers. Whether it goes anywhere is genuinely uncertain — legislation like this often takes years, if it moves at all — but it confirms this has moved from “something a few people noticed” to an active policy fight in Washington.
None of this changes what you can do right now day to day — the same practical steps still apply: know which PBM manages your benefit, ask whether you have a choice of pharmacy, and don’t assume “covered” means there’s no gap. But it’s worth knowing that when something about your coverage feels opaque or hard to untangle, you’re not imagining it, and you’re not the only one who’s noticed. Congress has now said so, on the record, from both sides of the aisle.
Frequently Asked Questions
Was this hearing about one political party’s concerns?
No — questioning came from both Democrat and Republican committee members, though they focused on somewhat different angles (drug pricing and self-dealing on one side, rural access to care and rate increases on the other).
Did the CEOs deny any of this?
Not the underlying structure — that’s public record. UnitedHealth’s CEO instead defended it as beneficial, arguing the integration improves care coordination and drives down costs through better data use.
Will the Senate bill actually pass?
That’s genuinely uncertain. Bills like this often take years to move, if they move at all. Its introduction is a sign of how seriously this is being taken in Washington, not a guarantee of a specific outcome.
Where can I read more about the hearing myself?
The House Energy and Commerce Committee and House Ways and Means Committee both maintain public records of committee hearings, including testimony and video, on their official House.gov pages.